Review Article
Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy
Table 8
Telaprevir Dosing in Treatment-Experienced Patients [
5].
|
Telaprevir 750 mg taken orally 3 times a day (7–9 hours apart) with food in combination with PEG-IFN/RBV for 12 weeks |
| Prior Relapse Patients | TVR/PEG-IFN/RBV | PEG-IFN/RBV | Total Duration |
| HCV RNA undetectable at weeks 4 and 12 | First 12 weeks | Additional 12 weeks | 24 weeks | HCV-RNA detectable (1000 IU/mL or less) at weeks 4 and/or 12 | First 12 weeks | Additional 36 weeks | 48 weeks | Prior Partial and Null Responder Patients | First 12 weeks | Additional 36 weeks | 48 weeks |
|
|